Tag: chemtai mungo

Chemtai Mungo, MD, MPH, FACOG, a member of the Institute for Global Health and Infectious Diseases and assistant professor of Obstetrics and Gynecology has been selected for the “Robert A. Winn Excellence in Clinical Trials: Career Development Award” (Winn CDA), a prestigious two-year national program that trains early-career physicians to...

Chemtai Mungo, MD, MPH, FACOG, has been awarded $2.5M over five years by the National Institutes of Health for her research focused on improving human papillomavirus (HPV) treatment outcomes in women living with HIV (WWH) in Africa. Dr. Mungo is an Assistant Professor in the UNC Department of Obstetrics and...

Cervical cancer remains a significant global health issue, especially in low- and middle-income countries (LMICs) where access to prevention and treatment is limited, and women are at a higher risk of cervical cancer. Artesunate, a widely available drug used to treat malaria, has shown promise in treating human papillomavirus (HPV)-associated...

Chemtai Mungo, MD, MPH, FACOG, a member of the Institute for Global Health and Infectious Diseases has been awarded the American Society of Clinical Oncology (ASCO) Career Development Award to support her research on the role of the vaginal microbiome in treatment outcomes following self-administered artesunate in the R34 trial she is...

Chemtai Mungo, MD, MPH, a member of the Institute for Global Health and Infectious Diseases, has been appointed to the Board of the International Papillomavirus Society (IPVS), the leading global authority on HPV (Human Papillomavirus)-related research and advocacy. The IPVS plays a crucial role in advancing scientific understanding, prevention, and...

Chemtai Mungo, MD, MPH, and Lisa Rahangdale, MD, MPH, presented at the American Society for Colposcopy and Cervical Pathology (ASCCP) meeting on May 4, focusing on the latest advancements in topical therapies for cervical precancer treatment in the U.S. and around the world. Dr. Mungo and Dr. Rahangdale, both obstetricians/gynecologists...

UNC researchers in cervical cancer prevention, members of the Institute for Global Health and Infectious Diseases and Lineberger Comprehensive Cancer Center, filled the agenda at a recent scientific session for the EUROGIN International Multidisciplinary HPV Conference in Stockholm, Sweden.       EUROGIN’s U.S. Chair Jennifer S. Smith, PhD, professor of...

During Cervical Cancer Awareness Month, Chemtai Mungo, MD, MPH, FACOG, a member of the Institute for Global Health and Infectious Diseases and an assistant professor of obstetrics and gynecology, was interviewed by Cancer Nursing Today, describing the role nurses can play in prevention and treatment. “Nurses interface with patients—women and men—throughout...